These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 3479699)
21. Introduction to a How I Treat series on sickle cell disease and thalassemia. Coates TD Blood; 2018 Oct; 132(17):1729-1730. PubMed ID: 30206114 [No Abstract] [Full Text] [Related]
22. Transfusion therapy in congenital hemolytic anemias. Sharon BI Hematol Oncol Clin North Am; 1994 Dec; 8(6):1053-86. PubMed ID: 7860437 [TBL] [Abstract][Full Text] [Related]
24. A nursing contribution to research issues in blood transfusion. Ballard S Prof Nurse; 2003 Feb; 18(6):308-9. PubMed ID: 12630239 [TBL] [Abstract][Full Text] [Related]
28. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease. Lebensburger J; Persons DA Curr Opin Drug Discov Devel; 2008 Mar; 11(2):225-32. PubMed ID: 18283610 [TBL] [Abstract][Full Text] [Related]
29. Yuet Wai Kan, MD: sickle cell and thalassemia pioneer. Interview by Tracy Hampton. Kan YW JAMA; 2006 Mar; 295(9):991. PubMed ID: 16507792 [No Abstract] [Full Text] [Related]
30. Globin gene transfer as a potential treatment for the beta-thalassaemias and sickle cell disease. Sadelain M Vox Sang; 2004 Jul; 87 Suppl 2():235-42. PubMed ID: 15209924 [No Abstract] [Full Text] [Related]
31. Frequency of pain crisis during pregnancy. Koshy M; Burd L; Dorn L; Huff G Prog Clin Biol Res; 1987; 240():305-11. PubMed ID: 3615495 [No Abstract] [Full Text] [Related]
32. Genetic blood disorders: questions you need to ask. Paul Starr S J Fam Pract; 2012 Jan; 61(1):30-7. PubMed ID: 22220293 [No Abstract] [Full Text] [Related]
33. [Response]. Dietzfelbinger H; Hubmann M Dtsch Med Wochenschr; 2015 Nov; 140(22):1647. PubMed ID: 26536633 [No Abstract] [Full Text] [Related]
34. Sickle cell anemia: targeting the role of fetal hemoglobin in therapy. Coleman E; Inusa B Clin Pediatr (Phila); 2007 Jun; 46(5):386-91. PubMed ID: 17556734 [TBL] [Abstract][Full Text] [Related]
35. Care for people with haemoglobin disorders. el-Hazmi MA World Health Forum; 1994; 15(2):165-8. PubMed ID: 8018282 [No Abstract] [Full Text] [Related]
36. Editorial of a special issue. Current status of therapeutics and preventive measures for patients with thalassaemia and sickle cell disease. Reddy PH Cardiovasc Hematol Agents Med Chem; 2012 Mar; 10(1):2. PubMed ID: 22239494 [No Abstract] [Full Text] [Related]
38. Towards gene therapy of hemoglobinopathies. Beuzard Y Semin Hematol; 1996 Jan; 33(1):43-52. PubMed ID: 8714584 [No Abstract] [Full Text] [Related]
39. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pakbaz Z; Fischer R; Fung E; Nielsen P; Harmatz P; Vichinsky E Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789 [TBL] [Abstract][Full Text] [Related]
40. Sickle cell and thalassaemia posts are good value and need protecting. Gillen S Nurs Stand; 2012 May 16-22; 26(37):14. PubMed ID: 22787884 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]